Speakers

Thursday, October 21st

Bob Taft, Governor of Ohio

Tony Dennis, PhD, Omeris President --view presentation--

Keynote Speaker:
Robert Day, MD, PhD, Founder of Epigenomics and President Emeritus of The Fred Hutchinson Cancer Research Center

Carlo Croce, MD, Incoming Chair Ohio State University's Department of Molecular Virology, Immunology, and Medical Genetics --view presentation--

David Scholl, PhD, President/CEO, Diagnostic Hybrids

Mike Hooven, Chairman/CTO, AtriCure

Gil Van Bokkelen, PhD, President/CEO, Athersys

Victoria Tifft, Founder & President, Clinical Research Management

Andrew Lefkowitz, President/CEO, Ganeden Biotech

Tim Biro, Partner, Reservoir Venture Partners, and Managing Partner, Ohio Innovation Fund

Friday, October 22nd

Omeris President Tony Dennis, PhD

Pat Valente, Deputy Director, Technology Division, Ohio Dept. of Development

Michael Knopp, MD, PhD, Novartis Chair of Imaging Research, The Ohio State University

John P. Pestian, PhD, MBA, Director, Center for Computational Medicine

Joe Hahn, MD, Chairman, CCF Innovations, The Cleveland Clinic --view presentation--

Marc Cloutier, PhD, Technology Division, Ohio Dept. of Development --view presentation--

John Rice, PhD, Managing Partner, Triathlon Medical Ventures --view presentation--

John Huston, Ohio TechAngel Fund --view presentation--

Don Lucas, PhD, Worldwide Strategic Alliances, Procter & Gamble Pharmaceuticals
--view presentation--

Barbara Fant, PharmD, Founding Partner, Integrated Center for Device Development

Catharina Maulbecker-Armstrong, PhD, Chairman Europe, Global Medical Forum Foundation

Mary Beth Privitera, Medical Device Innovation & Entrepreneurship Program, University of Cincinnati

Suzette Dutch, Managing Partner, Triathlon Medical Ventures

Carol Frankenstein, President, BIO/START

Lisa Han, Partner, Schottenstein Zox & Dunn